Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year-delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis

Autor:	D Cosgrove, C Wagner, M Blomley, C McClinton, A Steuer, J Gruber, Ravinder N. Maini, Peter C. Taylor, P Marsters
Jazyk:	angličtina
Rok vydání:	2016
Předmět:	musculoskeletal diseases medicine.medical_specialty Time Factors Combination therapy Immunology Placebo Gastroenterology law.invention Arthritis Rheumatoid chemistry.chemical_compound Rheumatology Randomized controlled trial immune system diseases law Internal medicine medicine Immunology and Allergy Humans Pharmacology (medical) skin and connective tissue diseases Ultrasonography business.industry Antibodies Monoclonal medicine.disease Infliximab Surgery Radiography Methotrexate chemistry Rheumatoid arthritis Antirheumatic Agents Antifolate Drug Therapy Combination business medicine.drug
Popis:	Objective To compare the impact of immediate and delayed introduction of anti–tumor necrosis factor therapy on inflammation and structural damage in methotrexate (MTX)–treated patients with early rheumatoid arthritis (RA). Methods Twenty-four patients with erosive early RA (duration
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a668260b957effedbcc6e1a348c6b44 https://ora.ox.ac.uk/objects/uuid:a937d904-522c-4435-8087-77db7532a4c1 Zobrazit plný text záznamu